3 month semaglutide program and Tirzepatide Rapid Weight loss Kick off the year with

Label also updated with clinical trials reports of dysesthesia (unpleasant or altered sense of touch)

Capsules are suitable for daily long-term use

Exosomes are tiny messenger particles that cells use to communicate with one another

The FDA has approved other GLP-1 drugs for Type 2 diabetes and weight loss

GLP-1 users losing significant weight face the clinically documented risk of muscle mass loss alongside fat loss a condition that has driven widespread adoption of high-protein diets among this population

Ozempic and GLP-1 usage by ethnicity Black and Hispanic Americans are more likely to use GLP-1 medications as compared to white Americans, aligning with higher obesity rates in these groups